研究者業績

川田 雅子

カワダ マサコ  (Kawada Masako)

基本情報

所属
自治医科大学 とちぎ子ども医療センター小児科 講師

J-GLOBAL ID
201401006387891850
researchmap会員ID
B000238662

外部リンク

論文

 25
  • 浅井 秀哉, 池田 尚広, 倉根 超, 川田 雅子, 山形 崇倫
    小児科臨床 75(1) 147-151 2022年2月  
  • Megumi Kobayashi, Takahiro Ikeda, Tatsuya Tokuda, Yukifumi Monden, Masako Nagashima, Sakae G Mizushima, Takeshi Inoue, Keiichi Shimamura, Yuta Ujiie, Akari Arakawa, Chie Kuroiwa, Mayuko Ishijima, Yuki Kishimoto, So Kanazawa, Takanori Yamagata, Masami K Yamaguchi, Ryoichi Sakuta, Ippeita Dan
    Neurophotonics 7(2) 025003-025003 2020年4月  査読有り
    Significance: It has been reported that children with attention-deficit hyperactivity disorder (ADHD) have impairment in the recognition of angry but not of happy facial expressions, and they show atypical cortical activation patterns in response to facial expressions. However, little is known about neural mechanisms underlying the impaired recognition of facial expressions in school-aged children with ADHD and the effects of acute medication on their processing of facial expressions. Aim: We aimed to investigate the possibility that acute administration of methylphenidate (MPH) affects processing of facial expressions in ADHD children. Approach: We measured the hemodynamic changes in the bilateral temporo-occipital areas of ADHD children observing the happy and angry facial expressions before and 1.5 h after MPH or placebo administration in a randomized, double-blind, placebo-controlled, crossover design study. Results: We found that, regardless of medication, happy expressions induced increased oxyhemoglobin (oxy-Hb) responses in the right inferior occipital region but not in the superior temporal region. For angry expressions, oxy-Hb responses increased after MPH administration, but not after placebo administration, in the left inferior occipital area, whereas there was no significant activation before MPH administration. Conclusions: Our results suggest that (1) ADHD children consistently recruit the right inferior occipital regions to process happy expressions and (2) MPH administration to ADHD children enhances cortical activation in the left inferior occipital regions when they process angry expressions.
  • Stephanie Sutoko, Yukifumi Monden, Tatsuya Tokuda, Takahiro Ikeda, Masako Nagashima, Tsukasa Funane, Hirokazu Atsumori, Masashi Kiguchi, Atsushi Maki, Takanori Yamagata, Ippeita Dan
    Frontiers in human neuroscience 14 3-3 2020年  査読有り
    Connectivity between brain regions has been redefined beyond a stationary state. Even when a person is in a resting state, brain connectivity dynamically shifts. However, shifted brain connectivity under externally evoked stimulus is still little understood. The current study, therefore, focuses on task-based dynamic functional-connectivity (FC) analysis of brain signals measured by functional near-infrared spectroscopy (fNIRS). We hypothesize that a stimulus may influence not only brain connectivity but also the occurrence probabilities of task-related and task-irrelevant connectivity states. fNIRS measurement (of the prefrontal-to-inferior parietal lobes) was conducted on 21 typically developing (TD) and 21 age-matched attention-deficit/hyperactivity disorder (ADHD) children performing an inhibitory control task, namely, the Go/No-Go (GNG) task. It has been reported that ADHD children lack inhibitory control; differences between TD and ADHD children in terms of task-based dynamic FC were also evaluated. Four connectivity states were found to occur during the temporal task course. Two dominant connectivity states (states 1 and 2) are characterized by strong connectivities within the frontoparietal network (occurrence probabilities of 40%-56% and 26%-29%), and presumptively interpreted as task-related states. A connectivity state (state 3) shows strong connectivities in the bilateral medial frontal-to-parietal cortices (occurrence probability of 7-15%). The strong connectivities were found at the overlapped regions related the default mode network (DMN). Another connectivity state (state 4) visualizes strong connectivities in all measured regions (occurrence probability of 10%-16%). A global effect coming from cerebral vascular may highly influence this connectivity state. During the GNG stimulus interval, the ADHD children tended to show decreased occurrence probability of the dominant connectivity state and increased occurrence probability of other connectivity states (states 3 and 4). Bringing a new perspective to explain neuropathophysiology, these findings suggest atypical dynamic network recruitment to accommodate task demands in ADHD children.
  • Stephanie Sutoko, Yukifumi Monden, Tatsuya Tokuda, Takahiro Ikeda, Masako Nagashima, Tsukasa Funane, Hiroki Sato, Masashi Kiguchi, Atsushi Maki, Takanori Yamagata, Ippeita Dan
    Neurophotonics 6(4) 045013-045013 2019年10月  査読有り
    Connectivity impairment has frequently been associated with the pathophysiology of attention-deficit/hyperactivity disorder (ADHD). Although the connectivity of the resting state has mainly been studied, we expect the transition between baseline and task may also be impaired in ADHD children. Twenty-three typically developing (i.e., control) and 36 disordered (ADHD and autism-comorbid ADHD) children were subjected to connectivity analysis. Specifically, they performed an attention task, visual oddball, while their brains were measured by functional near-infrared spectroscopy. The results of the measurements revealed three key findings. First, the control group maintained attentive connectivity, even in the baseline interval. Meanwhile, the disordered group showed enhanced bilateral intra- and interhemispheric connectivities while performing the task. However, right intrahemispheric connectivity was found to be weaker than those for the control group. Second, connectivity and activation characteristics might not be positively correlated with each other. In our previous results, disordered children lacked activation in the right middle frontal gyrus. However, within region connectivity of the right middle frontal gyrus was relatively strong in the baseline interval and significantly increased in the task interval. Third, the connectivity-based biomarker performed better than the activation-based biomarker in terms of screening. Activation and connectivity features were independently optimized and cross validated to obtain the best performing threshold-based classifier. The effectiveness of connectivity features, which brought significantly higher training accuracy than the optimum activation features, was confirmed (88% versus 76%). The optimum screening features were characterized by two trends: (1) strong connectivities of right frontal, left frontal, and left parietal lobes and (2) weak connectivities of left frontal, left parietal, and right parietal lobes in the control group. We conclude that the attentive task-based connectivity effectively shows the difference between control and disordered children and may represent pathological characteristics to be feasibly implemented as a supporting tool for clinical screening.
  • Stephanie Sutoko, Yukifumi Monden, Tatsuya Tokuda, Takahiro Ikeda, Masako Nagashima, Masashi Kiguchi, Atsushi Maki, Takanori Yamagata, Ippeita Dan
    Frontiers in human neuroscience 13 7-7 2019年  査読有り
    Attention deficit/hyperactivity disorder (ADHD) has been frequently reported as co-occurring with autism spectrum disorder (ASD). However, ASD-comorbid ADHD is difficult to diagnose since clinically significant symptoms are similar in both disorders. Therefore, we propose a classification method of differentially recognizing the ASD-comorbid condition in ADHD children. The classification method was investigated based on functional brain imaging measured by near-infrared spectroscopy (NIRS) during a go/no-go task. Optimization and cross-validation of the classification method was carried out in medicated-naïve and methylphenidate (MPH) administered ADHD and ASD-comorbid ADHD children (randomized, double-blind, placebo-controlled, and crossover design) to select robust parameters and cut-off thresholds. The parameters could be defined as either single or averaged multi-channel task-evoked activations under an administration condition (i.e., pre-medication, post-MPH, and post-placebo). The ADHD children were distinguished by significantly high MPH-evoked activation in the right hemisphere near the midline vertex. The ASD-comorbid ADHD children tended to have low activation responses in all regions. High specificity (86 ± 4.1%; mean ± SD), sensitivity (93 ± 7.3%), and accuracy (82 ± 1.6%) were obtained using the activation of oxygenated-hemoglobin concentration change in right middle frontal, angular, and precentral gyri under MPH medication. Therefore, the significantly differing MPH-evoked responses are potentially effective features and as supporting differential diagnostic tools.
  • Sutoko S, Monden Y, Funane T, Tokuda T, Katura T, Sato H, Nagashima M, Kiguchi M, Maki A, Yamagata T, Dand I
    Neurophotonics 5(4) 049801 2018年10月  査読有り
  • Ikeda Takahiro, Tokuda Tatsuya, Monden Yukifumi, Hirai Masahiro, Mizushima Sakae G, Nagashima Masako, Kyutoku Yasushi, Taniguchi Takamichi, Shimoizumi Hideo, Dan Ippeita, Yamagata Takanori
    JAPANESE PSYCHOLOGICAL RESEARCH 60(4) 251-264 2018年10月  査読有り
  • Stephanie Sutoko, Yukifumi Monden, Tsukasa Funane, Tatsuya Tokuda, Takusige Katura, Hiroki Sato, Masako Nagashima, Masashi Kiguchi, Atsushi Maki, Takanori Yamagata, Ippeita Dan
    Neurophotonics 5(4) 045001-045001 2018年10月  査読有り
    Functional near-infrared spectroscopy (fNIRS) signals are prone to problems caused by motion artifacts and physiological noises. These noises unfortunately reduce the fNIRS sensitivity in detecting the evoked brain activation while increasing the risk of statistical error. In fNIRS measurements, the repetitive resting-stimulus cycle (so-called block-design analysis) is commonly adapted to increase the sample number. However, these blocks are often affected by noises. Therefore, we developed an adaptive algorithm to identify, reject, and select the noise-free and/or least noisy blocks in accordance with the preset acceptance rate. The main features of this algorithm are personalized evaluation for individual data and controlled rejection to maintain the sample number. Three typical noise criteria (sudden amplitude change, shifted baseline, and minimum intertrial correlation) were adopted. Depending on the quality of the dataset used, the algorithm may require some or all noise criteria with distinct parameters. Aiming for real applications in a pediatric study, we applied this algorithm to fNIRS datasets obtained from attention deficit/hyperactivity disorder (ADHD) children as had been studied previously. These datasets were divided for training and validation purposes. A validation process was done to examine the feasibility of the algorithm regardless of the types of datasets, including those obtained under sample population (ADHD or typical developing children), intervention (nonmedication and drug/placebo administration), and measurement (task paradigm) conditions. The algorithm was optimized so as to enhance reproducibility of previous inferences. The optimum algorithm design involved all criteria ordered sequentially (0.047 mM mm of amplitude change, 0.029    mM    mm / s of baseline slope, and 0.6 × interquartile range of outlier threshold for each criterion, respectively) and presented complete reproducibility in both training and validation datasets. Compared to the visual-based rejection as done in the previous studies, the algorithm achieved 71.8% rejection accuracy. This suggests that the algorithm has robustness and potential to substitute for visual artifact-detection.
  • Nagashima M, Osaka H, Ikeda T, Matsumoto A, Miyauchi A, Kaneko K, Nakashima I, Nakano Y, Wakabayashi K, Monden Y, Yamagata T
    Brain & development 40(7) 607-611 2018年8月  査読有り
  • Ikeda T, Hirai M, Sakurada T, Monden Y, Tokuda T, Nagashima M, Shimoizumi H, Dan I, Yamagata T
    Neurophotonics 5(3) 035008-035008 2018年7月  査読有り
  • Miyauchi A, Osaka H, Nagashima M, Kuwajima M, Monden Y, Kohda M, Kishita Y, Okazaki Y, Murayama K, Ohtake A, Yamagata T
    Brain & development 40(6) 498-502 2018年6月  査読有り
  • Yukifumi Monden, Masako Nagashima, Haruka Dan, Takahiro Ikeda, Yasushi Kyutoku, Takanori Yamagata, Ippeita Dan
    High-Resolution Neuroimaging - Basic Physical Principles and Clinical Applications 2018年3月14日  
  • Hirokazu Yamagishi, Hitoshi Osaka, Masako Nagashima, Mari Kuwajima, Akihiko Miyauchi, Takahiro Ikeda, Karin Kojima, Ayumi Matsumoto, Takanori Yamagata
    Journal of the Japan Epilepsy Society 35(3) 693-701 2018年  査読有り
  • Sakamoto S, Monden Y, Fukai R, Miyake N, Saito H, Miyauchi A, Matsumoto A, Nagashima M, Osaka H, Matsumoto N, Yamagata T
    Brain & development 39(5) 439-443 2017年5月  査読有り
  • Yuko Nakano, Yukifumi Monden, Masashi Mizuguchi, Masako Nagashima, Yasunori Koike, Yuji Gunji, Naoto Takahashi, Hideo Sugie, MarikoY. Momoi, Takanori Yamagata
    Neurology Asia 20(1) 85-89 2015年3月  査読有り
  • Monden Y, Dan I, Nagashima M, Dan H, Uga M, Ikeda T, Tsuzuki D, Kyutoku Y, Gunji Y, Hirano D, Taniguchi T, Shimoizumi H, Watanabe E, Yamagata T
    NeuroImage. Clinical 9 1-12 2015年  査読有り
  • Nagashima M, Monden Y, Dan I, Dan H, Mizutani T, Tsuzuki D, Kyutoku Y, Gunji Y, Hirano D, Taniguchi T, Shimoizumi H, Momoi MY, Yamagata T, Watanabe E
    Neurophotonics 1(2) 025007-025007 2014年10月  査読有り
  • Mari Saito, Takanori Yamagata, Ayumi Matsumoto, Yusuke Shiba, Masako Nagashima, Shuhei Taniguchi, Eriko Jimbo, Mariko Y. Momoi
    BRAIN & DEVELOPMENT 36(1) 64-69 2014年1月  査読有り
  • Nagashima M, Monden Y, Dan I, Dan H, Tsuzuki D, Mizutani T, Kyutoku Y, Gunji Y, Hirano D, Taniguchi T, Shimoizumi H, Momoi MY, Watanabe E, Yamagata T
    NeuroImage. Clinical 6 192-201 2014年  査読有り
  • 門田行史, 檀はるか, 檀一平太, 長嶋雅子, 續木大介, 久徳康史, 山形崇倫, 郡司勇治, 渡辺英寿, 桃井真里子
    薬物脳波学会雑誌 (印刷中) 2013年  
  • Monden Y, Dan H, Nagashima M, Dan I, Tsuzuki D, Kyutoku Y, Gunji Y, Yamagata T, Watanabe E, Momoi MY
    NeuroImage : clinical 1(1) 131-140 2012年10月  査読有り
  • 門田行史, 檀はるか, 長嶋雅子, 檀一平太, 久徳康史, 岡本雅子, 山形崇倫, 桃井真里子, 渡辺英寿
    日本薬物脳波学会雑誌 13(1) 57-66 2012年6月5日  
  • Monden Y, Dan H, Nagashima M, Dan I, Kyutoku Y, Okamoto M, Yamagata T, Momoi MY, Watanabe E
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 123(6) 1147-1157 2012年6月  査読有り

MISC

 55

共同研究・競争的資金等の研究課題

 1